EQT-Led Traders Exit Galderma With Extra Than Fourfold Return

THE WHAT? An investor group led by EQT has exited its remaining stake in Swiss skincare firm Galderma by means of a significant share sale.

THE DETAILS EQT AB, the Abu Dhabi Funding Authority (ADIA) and Auba Funding Pte — backed by Singapore’s sovereign wealth fund GIC — offered their remaining shares in Galderma in a 4.89 billion Swiss francs (US$6.3 billion) transaction. The deal marked the ultimate stage of their exit technique, internally known as “Undertaking Indigo,” and was expanded twice as a result of robust investor demand.

The traders initially acquired Galderma from Nestlé in 2019 for round 10.2 billion francs, together with debt. Since then, they’ve progressively lowered their holdings by means of Galderma’s 2024 IPO and subsequent share placements. In whole, the traders have generated greater than 20 billion francs in proceeds from their funding. Galderma’s shares have risen greater than 180% for the reason that IPO, supported by robust monetary efficiency and demand for merchandise equivalent to Cetaphil and the injectable dermatitis remedy Nemluvio

THE WHY? The exit displays a profitable non-public fairness funding cycle following Galderma’s public itemizing and robust share worth efficiency.

Supply: Bloomberg